Candel Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $181 | 115 | 1.58 |
| 2023-12-31 | $165 | 113 | 1.47 |
| 2023-09-30 | $99 | 108 | 0.92 |
| 2023-06-30 | $130 | 104 | 1.26 |
| 2022-12-31 | $174 | 98 | 1.79 |
| 2022-09-30 | $0 | 96 | 0.00 |
| 2022-06-30 | $0 | 61 | 0.00 |
| 2021-09-30 | $12k | 1.1k | 11.00 |